Skip to main content
SpringerLink
Log in

The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans

  • Published:
Glycoconjugate Journal Aims and scope Submit manuscript

Abstract

The name glypican identifies a family of heparan sulfate proteoglycans that are linked to the cell surface by a glycosylphosphatidylinositol anchor. Members of this family have been identified in Drosophila, zebrafish, and mammals. The interest in the study of glypicans has increased in the last few years as a result of the discovery that the glypican-3 gene (GPC-3) is mutated in an overgrowth and dysmorphic syndrome. Despite the increased interest, our knowledge about the function of glypicans is still limited, since the molecular basis for the role of glypican-3 in the regulation of body size remains unknown. The in vivo manipulation of glypican expression in lower organisms, however, has demonstrated that these proteoglycans can modulate cellular responses to Wnts and bone morphogenetic factors . Future studies should investigate whether the phenotype of GPC-3-deficient individuals is also due to altered modulation of cellular responses to these factors. Published in 2003.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Filmus J, Song HH, in Glypicans, edited by Iozzo RV. Proteoglycans, New York, Marcel Dekker, pp. 161–76.

  2. Filmus J, Selleck SB, Glypicans: Proteoglycans with a surprise, J Clin Invest 108, 497–501 (2001).

    Google Scholar 

  3. Veugelers M, De Cat B, Ceulemans H, Bruystens AM, Coomans C, Durr J, Vermeesch J, Marynen P, David G, Glypican-6, a new member of the glypican family of cell surface proteoglycans, J Biol Chem 274, 26968–77 (1999).

    PubMed  Google Scholar 

  4. Saunders S, Paine-Saunders S, Lander AD, Expression of the cell surface proteoglycan glypican-5 is developmentally regulated in kidney, limb, and brain, Dev Biol 190, 78–93 (1997).

    PubMed  Google Scholar 

  5. David G, Lories V, Decock B, Marynen P, Cassiman J, Van Den Berghe H, Molecular cloning of a phosphatidylinositol-anchored membrane heparan sulfate proteoglycan from human lung fibroblasts, J Cell Biol 111, 3165–76 (1990).

    PubMed  Google Scholar 

  6. Stipp CS, Litwac ED, Lander AD, Cerebroglycan: An integral membrane heparan sulfate proteoglycan that is unique to the developing nervous system and expressed specifically during neuronal differentiation, J Cell Biol 124, 149–60 (1994).

    PubMed  Google Scholar 

  7. Filmus J, Church J, Buick RN, Isolation of a cDNA corresponding to a developmentally regulated transcript in rat intestine, Mol Cell Biol 8, 4243–9 (1988).

    PubMed  Google Scholar 

  8. Watanabe K, Yamada H, Yamaguchi Y, K-glypican: A novel GPIlinked heparan sulfate proteoglycan that is highly expressed in developing brain and kidney, J Cell Biol 130, 1207–18 (1995).

    PubMed  Google Scholar 

  9. Veugelers M, Vermeesch J, Reekmans G, Steinfeld R, Marynen P, David G, Characterization of glypican-5 and chromosomal localization of human GPC5, a new member of the glypican gene family, Genomics 40, 24–30 (1997).

    PubMed  Google Scholar 

  10. Paine-Saunders S, Viviano BL, Saunders S, GPC6, a novel member of the glypican gene family, encodes a product structurally related to GPC4 and is colocalized with GPC5 on human chromosome 13, Genomics 57, 455–8 (1999).

    PubMed  Google Scholar 

  11. Nakato H, Futch TA, Selleck SB, The division abnormally delayed (dally) gene: A putative integral membrane proteoglycan required for cell division patterning during postembryonic development of the nervous system in Drosophila, Development 121, 3687–702 (1995).

    PubMed  Google Scholar 

  12. Baeg GH, Lin X, Khare N, Baumgartner S, Perrimon N, Heparan sulfate proteoglycans are critical for the organization of the extracellular distribution of Wingless, Development 128, 87–94 (2001).

    PubMed  Google Scholar 

  13. Topczewsky J, Sepich DS, Myers DC, Walker C, Amores A, Lele Z, Hammerschmidt M, Postlethwait J, Solnica-Krezel L, The zebrafish glypican knypek controls cell polarity during gastrulation movements of convergent extension, Dev Cell 1, 251–64 (2001).

    PubMed  Google Scholar 

  14. Litwack ED, Stipp CS, Kumbasar A, Lander AD, Neuronal expression of glypican, a cell surface glycosylphosphatidylinositolanchored heparan sulfate proteoglycan, in the adult rat nervous system, J Neurosci 14, 3713–24 (1994).

    PubMed  Google Scholar 

  15. Ivins JK, Litwack ED, Kumbasar A, Stipp CS, Lander AD, Cerebroglycan, a developmentally regulated cell-surface heparan sulfate proteoglycan, is expressed on developing axons and growth cones, Dev Biol 184, 320–32 (1997).

    PubMed  Google Scholar 

  16. Pellegrini M, Pilia G, Pantano S, Lucchini F, Uda M, Fumi M, Cao A, Schlessinger D, Forabosco A, Gpc3 expression correlates with the phenotype of the Simpson-Golabi-Behmel syndrome, Dev Dyn 213, 431–9 (1998).

    PubMed  Google Scholar 

  17. Li M, Choo B, Wong Z-M, Filmus J, Buick RN, Expression of OCI-5/Glypican 3 during intestinal morphogenesis: Regulation by cell shape in intestinal epithelial cells, Exp Cell Res 235, 3–12 (1997).

    PubMed  Google Scholar 

  18. Veugelers M, Vermeesch J, Watanabe K, Yamaguchi Y, Marynen P, David G, GPC4, the gene for human K-glypican, flanks GPC3 on Xq26: Deletion of the GPC3-GPC4 gene cluster in one family with Simpson-Golabi-Behmel syndrome, Genomics 53, 1–11 (1998).

    PubMed  Google Scholar 

  19. Siebertz B, Stocker G, Drzeniek Z, Handt S, Just U, Haubeck H-D, Expression of glypican-4 in haematopoietic-progenitor and bone-marrow-stromal cells, Biochem J 344, 937–43 (1999).

    PubMed  Google Scholar 

  20. Fujise M, Izumi S, Selleck SB, Nakato H, Regulation of dally, an integral membrane proteoglycan, and its function during adult sensory organ formation of Drosophila, Dev Biol 235, 433–48 (2001).

    PubMed  Google Scholar 

  21. Lin X, Perrimon N, Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signaling, Nature 400, 281–4 (1999).

    PubMed  Google Scholar 

  22. Tsuda M, Kamimura K, Nakato H, Archer M, Staatz W, Fox B, Humphrey M, Olson S, Futch T, Kaluza V, Siegfried E, Stam L, Selleck SB, The cell-surface proteoglycan Dally regulates Wingless signaling in Drosophila, Nature 400, 276–80 (1999).

    PubMed  Google Scholar 

  23. Jackson SM, Nakato H, Sugiura M, Jannuzi A, Oakes R, Kaluza V, Golden C, Selleck SB, dally, a Drosophila glypican, controls celular responses to the TGF-beta-related morphogen Dpp, Development 124, 4113–20 (1997).

    PubMed  Google Scholar 

  24. Baeg GH, Perrimon N, Functional binding of secreted molecules to heparan sulfate proteoglycans in Drosophila, Curr Opin Cell Biol 12, 575–80 (2000).

    PubMed  Google Scholar 

  25. Binari RC, Staveley BE, Johnson WA, Godovarti R, Sasisekharan R, Manoukian AS, Genetic evidence that heparin-like glycosaminoglycans are involved in wingless signaling, Development 124, 2623–32 (1997).

    PubMed  Google Scholar 

  26. Haerry TE, Heslip TR, Marsh JL, O'Connor MB, Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila, Development 124, 3055–64 (1997).

    PubMed  Google Scholar 

  27. Reichsman F, Smith L, Cumberledge S, Glycosaminoglycans can modulate extracellular localization of the wingless protein and promote signal transduction, J Cell Biol 135, 819–27 (1996).

    PubMed  Google Scholar 

  28. Niehrs C, Solving a sticky problem, Nature 413, 787–8 (2001).

    PubMed  Google Scholar 

  29. Pilia G, Hughes-Benzie RM, MacKenzie A, Baybayan P, Chen EY, Huber R, Neri G, Cao A, Forabosco A, Schlessinger D, Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndrome, Nature Genet 12, 241–7 (1996).

    PubMed  Google Scholar 

  30. Neri G, Gurrieri F, Zanni G, Lin A, Clinical and molecular aspects of the Simpson-Golabi-Behmel syndrome, Am J Med Genet 79, 279–83 (1998).

    PubMed  Google Scholar 

  31. Hughes-Benzie RM, Pilia G, Xuan JY, Hunter AGW, Chen E, Golabi M, Hurst JA, Kobori J, Marymee K, Pagon RA, Punnett HH, Schelley S, Tolmie JL, Wohlferd MM, Grossman T, Schlessinger D, Mackenzie AE, Simpson-Golabi-Behmel syndrome: Genotype/phenotype analysis of 18 affected males from 7 unrelated families, Am J Med Genet 66, 227–34 (1996).

    PubMed  Google Scholar 

  32. Garganta CL, Bodurtha JN, Report of another family with Simpson-Golabi-Behmel syndrome and a review of the literature, Am J Med Genet 44, 129–35 (1992).

    PubMed  Google Scholar 

  33. Behmel A, Plochl E, Rosenkranz W, A new X-linked dysplasia gigantism syndrome: Identical with the Simpson dysplasia syndrome? Hum Genet 67, 409–13 (1984).

    PubMed  Google Scholar 

  34. Golabi M, Rosen L, A new X-linked mental retardation overgrowth syndrome, Am J Med Genet 17, 345–58 (1984).

    PubMed  Google Scholar 

  35. Lapunzina P, Badia I, Galoppo C, De Matteo E, Silberman P, Tello A, Grichener J, Hughes-Benzie R, A patient with Simson-Golabi-Behmel syndrome and hepatocellular carcinoma, J Med Genet 35, 153–6 (1998).

    PubMed  Google Scholar 

  36. Xuan JY, Hughes-Benzie RM, Mackenzie AE, A small interstitial deletion in the GPC3 gene causes Simpson-Golabi-Behmel syndrome in a Dutch-Canadian family, J Med Genet 36, 57–8 (1999).

    PubMed  Google Scholar 

  37. Hughes-Benzie RM, Hunter AGW, Allanson JE, Mackenzie AE, Simson-Golabi-Behmel syndrome associated with renal dysplasia and embryonal tumor: Localization of the gene to Xqcen-q21, Am J Med Genet 43, 428–35 (1992).

    PubMed  Google Scholar 

  38. Li M, Shuman C, Fei YL, Cutiongco E, Bender HA, Stevens C, Wilkins-Haug L, Day-Salvatore D, Yong SL, Geraghty MT, Squire JA, Weksberg R, GPC3 mutation analysis in a spectrum of patients with overgrowth expands the phenotype of Simpson-Golabi-Behmel syndrome, Am J Med Genet 102, 161–8 (2001).

    PubMed  Google Scholar 

  39. Cano-Gauci DF, Song H, Yang H, McKerlie C, Choo B, Shi W, Pullano R, Piscione TD, Grisaru S, Soon S, Sedlackova L, Tanswell AK, Mak TW, Yeger H, Lockwood GA, Rosenblum N, Filmus J, Glypican-3-deficient mice exhibit the overgrowth and renal abnormalities typical of the Simpson-Golabi-Behmel syndrome, J Cell Biol 146, 255–64 (1999).

    PubMed  Google Scholar 

  40. Paine-Saunders S, Viviano BL, Zupicich J, Skarnes WC, Saunders S, Glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development, Dev Biol 225, 179–87 (2000).

    PubMed  Google Scholar 

  41. Chiao E, Fisher P, Crisponi L, Deiana M, Dragatsis I, Schlessinger D, Pilia G, Efstratiadis A, Overgrowth of a mouse model of the Simpson-Golabi-Behmel syndrome is independent of IGF signaling, Dev Biol 243, 185–206 (2002).

    PubMed  Google Scholar 

  42. Duenas Gonzales A, Kaya M, Shi W, Song H, Testa JR, Penn LZ, Filmus J, OCI-5/GPC3, a glypican encoded by a gene that is mutated in the Simpson-Golabi-Behmel overgrowth syndrome, induces apoptosis in a cell line-specific manner, J Cell Biol 141, 1407–14 (1998).

    PubMed  Google Scholar 

  43. Weng EY, Mortier GR, Graham JM, Beckwith-Wiedemann syndrome, Clin Pediat 34, 317–26 (1995).

    PubMed  Google Scholar 

  44. Weksberg R, Squire JA, Molecular biology of Beckwith-Wiedemann syndrome, Med Pediatric Oncol 27, 462–9 (1997).

    Google Scholar 

  45. Weksberg R, Squire JA, Templeton DM, Glypicans: A growing trend, Nature Genet 12, 225–7 (1996).

    PubMed  Google Scholar 

  46. Eggenschwiler J, Ludwig T, Fisher P, Leighton PA, Tilghman SM, Efstratiadis A, Mouse mutant embryos overexpressing IGFII exhibit phenotypic features of the Beckwith-Wiedemann and Simpson-Golabi-Behmel syndromes, Genes & Develop 11, 3128–42 (1997).

    Google Scholar 

  47. Song HH, Shi W, Filmus J, OCI-5/rat glypican-3 binds to fibroblast growth factor-2 but not to insulin-like growth factor-2, J Biol Chem 272, 7574–7 (1997).

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sunnybrook and Women's College Health Sciences Centre, and Department of Medical Biophysics, University of Toronto, Canada

    Jorge Filmus

Authors
  1. Jorge Filmus
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jorge Filmus.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Filmus, J. The contribution of in vivo manipulation of gene expression to the understanding of the function of glypicans. Glycoconj J 19, 319–323 (2002). https://doi.org/10.1023/A:1025312819804

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025312819804

Search

Navigation